Members of several families of cell surface and secreted proteins bind glycosaminoglycans (GAGs), the structurally heterogeneous polysaccharides found on proteoglycans. To understand the physiological significance of the interactions of proteins with GAGs, it is critical that relationships between GAG structure and binding be analyzed. It is particularly important that interactions depending on common structural features of GAGs (e.g., size, charge density, and disaccharide repeat unit) be distinguished from those mediated by specific sequences of carbohydrate modification. Gathering the information needed to make such distinctions has so far been difficult, however, partly because structurally homogeneous samples of GAGs are lacking but also because of technical difficulties associated with performing and interpreting assays of protein-GAG binding. We describe an electrophoretic method useful for both measuring affinity and evaluating structural selectivity in protein-GAG binding. Data are presented on the binding of the GAG heparin to the protease inhibitor antithrombin III, the acidic and basic fibroblast growth factors, and the extracellular matrix protein fibronectin. Results obtained with fibronectin are consistent with a model in which high-affinity binding (Kd 34 nM) is mediated through the recognition of specific carbohydrate sequences.
Proteins that bind glycosaminoglycans (GAGs) include many cell adhesion molecules, glycoproteins of the extracellular matrix, polypeptide growth factors, secreted proteases and antiproteases, and proteins involved in lipoprotein uptake (1, 2) . In the tissue environments in which these proteins are found, GAGs are present as side chains of proteoglycans and exhibit diversity in length, disaccharide composition, and patterns of N-and 0-sulfation.
For most GAG-binding proteins, the relationship between GAG structure and binding affinity is poorly understood. For some, all that is known is that a high concentration of salt is required to elute them from heparin-agarose columns; sometimes the relative abilities of GAGs of different classes (e.g., heparan sulfate, chondroitin sulfate, dermatan sulfate, keratan sulfate, etc.) to compete away such binding has also been measured (e.g., refs. 3 and 4). Those direct measurements of affinity that have been made have often required derivatization or immobilization of either protein or GAG (e.g., refs. 5-7); such measures may inhibit (e.g., by blocking sites of interaction) or artificially enhance (e.g., by favoring multivalent interactions) binding. Quantifying binding is also impeded by the fact that most GAG-protein Kd values are thought to be in the range of 5-500 nM, where the possibility of rapid dissociation kinetics argues against the use of many types of binding assays that involve separation and washing of bound complexes. In addition, measurements that have been made of GAG-protein affinity have usually measured the average affinity of a protein for the structurally heterogenous set of binding sites represented by any GAG sample. Selectivity of a protein for specific sequences of carbohydrate modification is, therefore, not readily appreciated, despite the fact that such selectivity exists and is, in at least one case, of considerable physiological importance (8) .
Below, experiments are presented in which the principle of affinity electrophoresis (9) was exploited to analyze protein-GAG binding. The technique described is referred to as affinity coelectrophoresis (ACE) because both protein and GAG are permitted to migrate freely during electrophoresis (typically, in affinity electrophoresis, as in affinity chromatography, one ligand is physically immobilized). The method uses small amounts of material and can yield values of the affinity constant even when dissociation is rapid (e.g., when affinity is low). Experiments are presented in which ACE was used to identify and isolate a subpopulation of heparin molecules to which fibronectin binds selectively. Some of these data have been presented in abstract form (10, 11) .
MATERIALS AND METHODS
Materials. Low-melting-point agarose (SeaPlaque) and GelBond were purchased from FMC, heparin (grade I, from porcine intestinal mucosa) was from Sigma, chondroitin sulfate (from shark cartilage) was from Fluka, bovine serum albumin (crystalline) was from ICN, and human plasma fibronectin (FN) was from New York Blood Center (New York). Basic fibroblast growth factor (bFGF) and acidic fibroblast growth factor (aFGF) were purified from bovine brain (12) . Human antithrombin III (AT) was the generous gift of Robert Rosenberg (M.I.T.). p8-Nerve growth factor was generously donated by Randall Pittman (University of Pennsylvania).
Heparin was substituted with fluoresceinamine to a level of 15.7 ng/,ug (13) and radioiodinated to a specific activity of 110,000 cpm/ng (14) . A portion of the 125I-labeled fluoresceinamine-heparin (125I-F-heparin) was fractionated by gel filtration [on Sephadex G-100 in 50 mM sodium 3-(Nmorpholino)-2-hydroxypropanesulfonate) (Mopso), pH 7.0/ 125 mM sodium acetate] and the last 10.8% of the radioactive material to elute (0.57 < Ka, < 0.76) was pooled as a low molecular weight (LMW) fraction. This fraction was estimated to contain heparin chains of Mr -6000 (3, (15) (16) (17) (18) .
Electrophoretic Analysis of Binding. Low-melting-point agarose (1%) was prepared in either of two electrophoresis buffers: 50 mM sodium Mopso, pH 7.0/125 mM sodium acetate/0. tTo whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Typically, electrophoresis was performed at 60-70 V (2-2.4 V/cm) for 0.75-2 hr, with currents of -330 mA (in buffer A). Buffer was recirculated, and a flow of cold tap water through the coolant ports of the apparatus was used to maintain buffer temperature at 20-250C. Endpoints were determined by the position of the bromphenol blue, which migrated about half as rapidly as heparin. Gels were air-dried and autoradiographed against preflashed film at -80'C. In some experiments, 125I-F-heparin was recovered from gels by electroelution in 0.75 mM NaOAc/0.25 mM sodium Mopso, pH 7, concentrated 2-fold using a SpeedVac evaporator (Savant), and retested for binding using ACE.
RESULTS
Demonstration of Protein-GAG Binding. At neutral pH, the electrophoretic mobilities of most proteins are much lower than those of GAGs. Consequently, the binding ofproteins to GAGs should, in most cases, retard GAG electrophoresis. To determine whether this effect could be exploited to quantify protein-GAG binding, a method was devised for electrophoresing labeled GAGs though zones containing multiple protein samples. Briefly, special combs were used to create agarose gels of the configuration shown in Fig. IA . The long rectangles represent wells into which proteins in molten low-gelling-temperature agarose (at 370C) could be introduced and allowed to gel. The dark line at the top of Fig. lA indicates where samples of labeled GAGs were introduced. The position of the anode is at the bottom. Fig. 1B presents the expected experimental results when the nine wells contain a single GAG-binding protein at a series of concentrations decreasing from left to right: at sufficiently high protein concentrations, migration of the GAG front (thick black line) is retarded in a dose-dependent manner. The protein-free spaces between the wells facilitate measurement of the changes in mobility associated with each protein concentration. Fig. 2A shows that the predicted pattern was indeed obtained when 251I-F-heparin was electrophoresed at neutral pH and physiological ionic strength through zones containing a known heparin-binding protein, bFGF. In response to bFGF concentrations of up to 35 nM, heparin mobility was reduced up to 88%. The effect was specific, in that even much higher concentrations of nerve growth factor (a protein of similar size and isoelectric point to bFGF) had no effect on 125I-F-heparin mobility (Fig. 2B ).
An assumption made in predicting the simple pattern shown in Fig. 1B was that all heparin molecules behave more or less identically. The data in Fig. 2 A and B support this assumption. In contrast, experiments performed with a different heparin-binding protein, AT, illustrate the type of pattern that can result when heparin molecules do not behave identically (Fig. 2C ). In this case, the migrating heparin front was split by AT into two distinct fronts, one of which was progressively slowed by AT concentrations 25 nM, whereas the other was shifted only slightly by AT at 1 ,uM. The same result was obtained with a size-selected LMW fraction of 125I-F-heparin (Fig. 2D) . A large excess of unlabeled heparin '"I-F-heparin to AT by unlabeled heparin. In this experiment, a gel was cast with three sample slots, each opposite three of nine rectangular zones. Equal amounts of 1251-F-heparin were introduced into each slot. In the central slot, unlabeled heparin (1 mg/ml) was mixed with the labeled sample; in the slot at right, unlabeled chondroitin sulfate (1 mg/ml) was added. Concentrations of AT are in nM. (F) Recovery and analysis of heparin with high and low affinity for AT. A set of three sample slots was prepared as in E. Into the slot at left was loaded material isolated from LMW 1251-F-heparin that had previously migrated through AT-containing agarose without retardation (lanes Low-Aff.). Material that had been retarded by AT was isolated and loaded in the central slot (lanes High-Aff.). Control 1251-F-heparin was loaded in the slot at right.
Concentrations of AT are shown in nM.
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.ilor readily blocked the effects of AT on heparin mobility, but an equal concentration of chondroitin sulfate did not (Fig. 2E) . These results fit with what is known about the properties of AT, one of the most studied GAG-binding proteins: AT binds a subset of heparin molecules, with subtleties of carbohydrate sequence, rather than heparin chain length, providing the basis for selectivity (19) . To confirm that the two heparin fronts observed in ACE gels containing AT actually result from the fractionation of heparin into distinct species with different binding properties, a gel similar to the one shown in Fig. 2D was electrophoresed and pieces of agarose were cut out of locations where the two heparin fronts were well separated. The pieces were then melted, and their contents were retested for binding to AT. The results (Fig. 2F) confirm that separable fractions of heparin account for the pattern in Fig. 2D .
Measurement of Binding Affinity. In general, heparin's mobility in any protein-containing environment should be the average of the mobilities of protein-bound heparin and free heparin, weighted according to the fraction of time that heparin molecules spend in the bound and free states. To quantify protein-induced shifts in mobility, it is convenient to introduce a unitless number, the retardation coefficient Two such plots are shown in Fig. 3 . The data for bFGF binding to LMW heparin ( Fig. 2A) (Fig. 3B) . Straight lines also fit the data obtained for the binding of unfractionated heparin to bFGF and AT, and for the binding of heparin to aFGF and serum albumin (data not shown). These findings are summarized in Table 1 . Results with two buffer systems that differed in their major anion (chloride vs. acetate) did not differ significantly.
Characterization of Heparin Binding to FN. FN is a major glycoprotein of the extracellular matrix and a component of plasma (20, 21) . FN binds heparin and heparan sulfate (3, 22, 23) , whereupon alterations in its structural properties and ability to bind other molecules can be detected (e.g., refs. [24] [25] [26] . Recent evidence indicates that the attachment of epithelial cells and fibroblasts to FN is mediated, in part, by cell surface heparan sulfate (27, 28) . Plasma FN, a disulfide-linked dimer, is eluted from heparinSepharose between 0.3 and 0.5 M NaCl (29 12 ,000) were used in that study (3) .
Analysis of the heparin-FN interaction by ACE is shown in Fig. 4A . At high FN concentrations, LMW 125I-F-heparin was observed to shift to a single very low mobility, implying that essentially all heparin molecules bind FN. At somewhat lower FN concentrations, however, the labeled material migrated not as a discrete band but as a diffuse smear. It seemed likely that this smear represented the fractionation of individual heparin molecules according to differences in affinity for FN.
To test this possibility, LMW 125I-F-heparin was electrophoresed through a single zone of 125 nM FN. The gel was then cut transversely into segments, and fractions were pooled representing the leading 26% of the 125I-F-heparin (pool 1, "weakly retarded heparin") and the trailing 26% (pool 2, "strongly retarded heparin"). The samples were heated to 100TC for 10 min (to denature FN) and labeled heparin was recovered by electroelution. The resulting material was retested for binding to FN. As shown in Fig. 4 B and C, the ACE patterns for pools 1 and 2 were distinctly different from each other and considerably less diffuse than those of the starting material.
Graphical analysis ofthe patterns in Fig. 4 B and C is shown in Fig. 5 . The data from pool 1 yield a linear plot, suggesting a Kd of 640 nM. Pool 2 yields an apparently discontinuous plot-two line segments with similar slopes (implying Kd values of 32 and 36 nM). Examination of Fig. 4C indicates how the result for pool 2 arises: with increasing FN concentration, heparin's mobility decreases, levels off at R 0.5, tEstimated from data in Fig. 2C and the assumption that R. for low-affinity heparin will be the same as that observed for highaffinity heparin. tFrom the experiment described in Figs. 4 and 5. §Highest concentration tested.
Proc. Natl. Acad. Sci. USA 88 (1991) In n7 Fig. 1 Fig. 4 Proc. Natl. Acad. Sci. USA 88 (1991) 2771 filtration on Sephadex G-75 in 10 mM Mopso, pH 7.0/125 mM sodium acetate/4 M urea. The size distributions of molecules in pools 1 and 2 were largely overlapping, with those of pool 1 being slightly smaller (Ka, = 0.250) and those in pool 2 slightly larger (Kav = 0.162) than the LMW heparin from which both pools were derived (Kay = 0.235) (data not shown). To assess whether the molecules in pools 1 and 2 differed greatly in charge density (a reflection of the degree of sulfation), their electrophoretic mobilities in 1% agarose (containing no binding proteins) were compared. The mobilities obtained for the two pools were identical: 5.6 ± 0.03 x 10-8 m2/V s for pool 1 and 5.6 ± 0.05 x 10-8 m2/V s for pool 2 (in buffer A at 25TC). DISCUSSION
We report here the development of an affinity-electrophoretic technique, ACE, for studying GAG-protein interactions. Binding is measured at physiological pH and ionic strength and under conditions in which interacting molecules are freely mobile. ACE can in principle be used to measure binding between any two macromolecules, provided that the complex they form has an electrophoretic mobility different from that of at least one of its components. In practice, this difference should be large enough that distances migrated by bound and free ligand are distinguishable within reasonable time. In some of the experiments described above, it was possible to achieve sufficient separations with electrophoresis of the GAG front through only 20 mm of gel; in no experiment was electrophoresis through >50 mm necessary.
These distances required short electrophoresis times at modest field strengths (e.g., 2.4 V/cm for 1-2 hr). Also, because electrophoresis was carried out in a gel of small width and height, little material was required. For example, to measure binding of heparin to AT in Fig. 2E , only 400 pmol of protein and 75 fmol of GAG were used. Considering that ACE can measure affinities when dissociation rates are fast and that other techniques for doing so [e.g., equilibrium gel filtration (31, 32) ] can require large amounts of material, the sensitivity of ACE seems particularly good. Accurate determination of affinity constants using ACE requires that the following conditions be met. Also, electrophoresis was performed using a highly porous matrix (1% agarose) to minimize effects of sieving on molecular interactions, and electrophoresis times were long (1-2 hr) compared with likely kinetic constants.
As shown in Figs. 3 Indeed, the same phenomenon has been observed with AT: fractionation of heparin populations by their affinity for AT produces a high-affinity fraction with an average size slightly larger than the low-affinity fraction (15, 16) despite the fact that the binding of AT is mediated by a specific short carbohydrate sequence (19) .
If, as the data presented here suggest, FN recognizes specific carbohydrate sequences on heparin, it will be important to investigate the binding of FN to heparan sulfates, which bear the same carbohydrate modifications as heparin but which are widely distributed in vivo. Interestingly, large differences have been reported in the degree to which heparan sulfates from different sources bind FN (e.g., refs. 3 and 37). These results raise the possibility that cells, by controlling specific steps in GAG modification, could modulate their ability to use heparan sulfate as a cell-surface receptor for FN (27, 28) .
